PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma

In head and neck squamous cell carcinoma (HNSCC), data from studies using checkpoint-inhibiting antibodies that target programmed death 1 (PD-1) or its ligand the programmed death ligand 1 (PD-L1) demonstrated outstanding clinical activity. Translational investigations also suggested some correlatio...

Full description

Bibliographic Details
Main Authors: D. Evrard, M. Hourseau, A. Couvelard, V. Paradis, H. Gauthier, E. Raymond, C. Halimi, B. Barry, S. Faivre
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
head and neck squamous cell carcinoma
immune checkpoint inhibitors
anti-pd-1/pd-l1
biomarkers
tumor microenvironment
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1844403

Internet

http://dx.doi.org/10.1080/2162402X.2020.1844403

Similar Items